Cluster Articles

Pages linked into this editorial category.

Martin Shkreli and EpiPen: Pricing, Influence, and Public Reaction

Martin Shkreli became a symbol of drug pricing controversy amid EpiPen debates, though he did not own or directly set EpiPen prices. His company, Turing Pharmaceuticals, acquire...

Read article